The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators
Article in Frontiers in Physiology (March 2022)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
Article in Hepatology Communications (September 2020)
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Article in Metabolism (July 2020)